A Non-interventional, Observational Study for Targinact® Treatment in Patients With Chronic Severe Pain
CompletedNCT01710904
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This non-interventional, observational study is set up on request of the Belgian reimbursement authorities and evaluates the efficacy of Targinact with regard to pain relief and constipation in daily clinical practice in Belgium compared to the previous analgesic treatment with prolonged release oxycodone. Only patients eligible for Targinact® reimbursement in Belgium are included.
Study details
- Official title
- The Evaluation of Targinact® in Daily Practice, With Regards to Pain Relief and Constipation, in Chronic Severe Pain Patients Compared to Previous Prolonged Release Oxycodone Treatment: a Non-interventional, Observational Study.
- Conditions
- Chronic Severe Pain
- Interventions
- Drug: Targinact® (oxycodone/naloxone)
- Sponsor
- Mundipharma CVA
- Start date
- 2012-09
- Primary completion
- 2013-07
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Belgium
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion criteria: patients included are patients who * are eligible for Targinact® treatment according to the Targinact® SPC AND * who have previously been treated with PR oxycodone during at least the last 30 days before study inclusion AND * who are constipated (BFI \> 30) AND * have used at least 2 laxatives with different modes of action during the previous PR oxycodone treatment Exclusion criteria are based on Targinact® SPC.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01710904